Diag2Tec
|
Year Established:
2015 |
|
|
Website:
diag2tec.com |
|
|
Headquarters:
Montpellier cedex 5, , FR |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
|
|
Completed Requests:
5 |
Diag2Tec is a preclinical CRO devoted to Hematological Malignancies.
We provide preclinical services including in vitro Drug Testing in Multiple Myeloma, Lymphoma, Leukemia derived Cell lines and Primary Cells from patients.
With our unique cellular models, genomic data, and our expertise, our mission is to provide efficient treatment solutions for patients suffering from Hematological Malignancies with Precision Medicine approaches. We support biotech and pharmaceutical companies to focus their preclinical drug development on the right molecules in the right indications.
| Site | Badges | |
|---|---|---|
| DIAG2TEC STI, Dept d'Hématologie Biologique, Hôpital Saint-Eloi - CHRU de Montpellier, 80 av. Augustin Fliche Montpellier cedex 5, , 34295 France | ||
| DIAG2TEC STI, Dept d'Hématologie Biologique, Hôpital Saint-Eloi - CHRU de Montpellier, 80 av. Augustin Fliche Montpellier cedex 5, , 34295 France | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.